| 1 |
Pandiri M, Nukala SK, Swamy TN, Dasari G, Badithapuram V, Manchal R, Bandari S. Design, Synthesis, and Anticancer Activity of Some New N-{5-[(1H-Benzo[d]imidazol-1-yl)methyl]isoxazol-3-yl}benzamide Hybrids. Russ J Gen Chem 2021;91:2320-6. [DOI: 10.1134/s1070363221110207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Popov AB, Krstulović L, Koštrun S, Jelić D, Bokulić A, Stojković MR, Zonjić I, Taylor MC, Kelly JM, Bajić M, Raić-Malić S. Design, synthesis, antitrypanosomal activity, DNA/RNA binding and in vitro ADME profiling of novel imidazoline-substituted 2-arylbenzimidazoles. Eur J Med Chem 2020;207:112802. [PMID: 32927230 DOI: 10.1016/j.ejmech.2020.112802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Helal MA, Chittiboyina AG, Avery MA. Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening. Bioorg Med Chem Lett 2019;29:126741. [PMID: 31678007 DOI: 10.1016/j.bmcl.2019.126741] [Reference Citation Analysis]
|
| 4 |
Mouselmani R, Hachem A, Alaaeddine A, Métay E, Lemaire M. Reduction of aromatic nitriles into aldehydes using calcium hypophosphite and a nickel precursor. Org Biomol Chem 2018;16:6600-5. [PMID: 30175348 DOI: 10.1039/c8ob01751d] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 5 |
Guyon C, Métay E, Popowycz F, Lemaire M. Synthetic applications of hypophosphite derivatives in reduction. Org Biomol Chem 2015;13:7879-906. [DOI: 10.1039/c5ob01032b] [Cited by in Crossref: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 6 |
Gaspar A, Matos MJ, Garrido J, Uriarte E, Borges F. Chromone: A Valid Scaffold in Medicinal Chemistry. Chem Rev 2014;114:4960-92. [DOI: 10.1021/cr400265z] [Cited by in Crossref: 374] [Cited by in F6Publishing: 251] [Article Influence: 46.8] [Reference Citation Analysis]
|
| 7 |
Högberg T, Frimurer TM, Sasmal PK. Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment? Bioorganic & Medicinal Chemistry Letters 2012;22:6039-47. [DOI: 10.1016/j.bmcl.2012.08.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Guo D, Klaasse E, de Vries H, Brussee J, Nalos L, Rook MB, Vos MA, van der Heyden MA, Ijzerman AP; Shagufta. Exploring chemical substructures essential for HERG k(+) channel blockade by synthesis and biological evaluation of dofetilide analogues. ChemMedChem 2009;4:1722-32. [PMID: 19725081 DOI: 10.1002/cmdc.200900203] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Ali TE, Ibrahim MA, Abdel-kariem SM. Synthesis of Biologically Active 4-Oxo-4 H -Chromene Derivatives Containing Sulfur-Nitrogen Heterocycles. Phosphorus, Sulfur, and Silicon and the Related Elements 2009;184:2358-92. [DOI: 10.1080/10426500802473094] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 10 |
Méndez-andino JL, Wos JA. MCH-R1 antagonists: what is keeping most research programs away from the clinic? Drug Discovery Today 2007;12:972-9. [DOI: 10.1016/j.drudis.2007.08.010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 11 |
Rokosz LL. Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Expert Opinion on Drug Discovery 2007;2:1301-27. [DOI: 10.1517/17460441.2.10.1301] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
|
